About Clinical Microbiomics
Clinical Microbiomics is a company based in Hørsholm (Denmark) founded in 2016. Clinical Microbiomics has raised $9.71 million across 4 funding rounds from investors including European Union and Seventure Partners. The company has 35 employees as of November 30, 2024. Clinical Microbiomics has completed 2 acquisitions, including DNASense and MS-Omics. Clinical Microbiomics offers products and services including Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration. Clinical Microbiomics operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, BGI, Genewiz and Beikang Medical, among others.
- Headquarter Hørsholm, Denmark
- Employees 35 as on 30 Nov, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinical-Microbiomics A/S
-
Annual Revenue
Not available
-
Net Profit
-$978.52 K (USD)-301as on Dec 31, 2022
-
EBITDA
-$1.02 M (USD)-183as on Dec 31, 2022
-
Total Equity Funding
$9.71 M (USD)
in 4 rounds
-
Latest Funding Round
$9.71 M (USD), Series A
Oct 11, 2022
-
Investors
European Union
& 1 more
-
Employee Count
35
as on Nov 30, 2024
-
Investments & Acquisitions
DNASense
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Microbiomics
Clinical Microbiomics offers a comprehensive portfolio of products and services, including Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration.
Service for profiling microbial communities in samples using sequencing techniques.
Analysis of microbial metabolic fingerprints for health and disease research.
Tool for assessing microbiome abundances and functional aspects in human studies.
Combines genomics and metabolomics data for comprehensive biological insights.
Funding Insights of Clinical Microbiomics
Clinical Microbiomics has successfully raised a total of $9.71M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.71 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clinical Microbiomics
Clinical Microbiomics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Seventure Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Clinical Microbiomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clinical Microbiomics
Clinical Microbiomics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include DNASense and MS-Omics.
Investment portfolio details for Clinical Microbiomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genetic engineering services including sequencing and metagenomics are provided.
|
Locked | Locked | 2014 | Locked | |
|
Metabolomics and data analysis platform is provided by MS-Omics.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Clinical Microbiomics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Clinical Microbiomics
Detailed financials for Clinical Microbiomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinical Microbiomics Comparisons
Peer comparison for Clinical Microbiomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clinical Microbiomics
Clinical Microbiomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, BGI, Genewiz and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Clinical Microbiomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinical Microbiomics
Complete news archive for Clinical Microbiomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinical Microbiomics
Clinical Microbiomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Clinical Microbiomics is headquartered in Hørsholm, Denmark.
Clinical Microbiomics is a funded company, having raised a total of $9.71M across 4 funding rounds to date.
As of Nov 30, 2024, the latest employee count at Clinical Microbiomics is 35.
Clinical Microbiomics was founded in 2016 in Horsholm, Denmark, as a provider in the microbiome sector. A range of services is offered, including kits supply, sample storage, metagenomics, transcriptomics, specialized characterization through real-time qPCR and strain typing, bioinformatics, and statistical analysis. Customized sequencing solutions are developed according to specific project requirements.
Clinical Microbiomics's top competitors include Novogene Corporation, BGI and Source BioScience.
Clinical Microbiomics offers Metagenomics, Metabolomics, Human Microbiome Profiling, and Multi-omics Data Integration.
Clinical Microbiomics has 2 investors. Key investors include European Union, and Seventure Partners.